{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:20:21Z","timestamp":1794565221465,"version":"4.9.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Lassa fever (LF) is a zoonotic infectious disease of public concern in Nigeria. The infection dynamics of the disease is not well elucidated in Nigeria. This study was carried out to describe the pattern of infection, case fatality rate and spread of lassa virus (LASV) from 2017 to 2020.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Weekly epidemiological data on LF from December, 2016 to September, 2020 were obtained from Nigeria Centre for Disease Control. The number of confirmed cases and deaths were computed according to months and states. Descriptive statistics was performed and case fatality rate was calculated. Distribution and spread maps of LF over the four years period was performed on ArcMap\u00a010.7.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 2787 confirmed cases and 516 deaths were reported in Nigeria from December, 2016 to September, 2020. Increase in number of cases and deaths were observed with 298, 528, 796 and 1165 confirmed cases and 79, 125, 158 and 158 deaths in 2017, 2018, 2019 and 2020 respectively. Over 60% of the cases were reported in two states, Edo and Ondo states. The LF cases spread from 19 states in 2017 to 32 states and Federal Capital Territory (FCT) in 2020. Ondo state (25.39%) had the highest of deaths rate from LF over the four years. Case fatality rate (CFR) of LF was highest in 2017 (26.5%) with CFR of 23.7, 19.6 and 13.4% in 2018, 2019 and 2020 respectively. The peak of infection was in the month of February for the four years. Infections increases at the onset of dry season in November and decline till April when the wet season sets-in.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>There is an annual increase in the number of LASV infection across the states in Nigeria. There is need to heighten control strategies through the use of integrated approach, ranging from vector control, health education and early diagnosis.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12879-021-05837-x","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T12:09:02Z","timestamp":1612526942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Infection pattern, case fatality rate and spread of Lassa virus in Nigeria"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9214-6095","authenticated-orcid":false,"given":"Clement Ameh","family":"Yaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezekiel","family":"Kogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth Nnamdi","family":"Opara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5324-0014","authenticated-orcid":false,"given":"Roua S.","family":"Baty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Albrakati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farag M. A.","family":"Altalbawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Innocent Utenwojo","family":"Etuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Paul","family":"Oni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"issue":"12","key":"5837_CR1","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.3390\/v4102031","volume":"4","author":"NE Yun","year":"2012","unstructured":"Yun NE, Walker DH. Pathogenesis of Lassa fever. Viruses. 2012;4(12):2031\u201348 https:\/\/dx.doi.org\/10.3390%2Fv4102031.","journal-title":"Viruses."},{"key":"5837_CR2","doi-asserted-by":"publisher","unstructured":"Radoshitzky SR, Buchmeier MJ, Charrel RN, Clegg JCS, Gonzalez J-PJ, Gunther S, Hepojoki J, Kuhn JH, Lukashevich IS, Romanowski V, Salvato MS, Sironi M, Steglein MD, de la Torre JC, ICTV report consortium. ICTV virus taxonomy profile: Arenaviridae. J Gen Virol 2019;100:1200\u20131201. https:\/\/doi.org\/https:\/\/doi.org\/10.1099\/jgv.0.001280.","DOI":"10.1099\/jgv.0.001280"},{"key":"5837_CR3","doi-asserted-by":"publisher","unstructured":"Frame JD, Baldwin JMJ, Gocke DJ, Troup JM. Lassa fever, a new virus disease of man from West Africa. Am J Trop Med Hyg. 1970;19: 670\u2013676. https:\/\/doi.org\/https:\/\/doi.org\/10.4269\/ajtmh.1970.19.670.","DOI":"10.4269\/ajtmh.1970.19.670"},{"issue":"3","key":"5837_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3390\/v12030312","volume":"12","author":"A Olayemi","year":"2020","unstructured":"Olayemi A, Fichet-Calvet E. Systematics, ecology, and host switching: attributes affecting emergence of the Lassa virus in rodents across Western Africa. Viruses. 2020;12(3):312 https:\/\/dx.doi.org\/10.3390%2Fv12030312.","journal-title":"Viruses."},{"key":"5837_CR5","doi-asserted-by":"publisher","unstructured":"Olayemi A, Cadar D, Magassouba N, Obadare A, Kourouma F, Oyeyiola A, Fasogbon S, Igbokwe J, Rieger T, Bockholt S, et al. New hosts of the Lassa virus. Sci Rep 2016;6:25280. https:\/\/doi.org\/https:\/\/doi.org\/10.1038\/srep25280.","DOI":"10.1038\/srep25280"},{"issue":"1","key":"5837_CR6","first-page":"1","volume":"44","author":"O Ogbu","year":"2007","unstructured":"Ogbu O, Ajuluchukwu E, Uneke CJ. Lassa fever in west African sub-region: an overview. J Vector Borne Dis. 2007;44(1):1\u201311.","journal-title":"J Vector Borne Dis"},{"key":"5837_CR7","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1136\/bmj.327.7426.1271","volume":"327","author":"JK Richmond","year":"2003","unstructured":"Richmond JK, Baglole DJ. Lassa fever: epidemiology, clinical features, and social consequences. BMJ. 2003;327:1271\u20135 https:\/\/dx.doi.org\/10.1136%2Fbmj.327.7426.1271.","journal-title":"BMJ."},{"key":"5837_CR8","unstructured":"Centers for Disease Control (CDC). Lassa fever. Centre for Disease Control; 2019. www.cdc.gov\/vhf\/lassa. Retrieved 31st October, 2020."},{"key":"5837_CR9","unstructured":"World Health Organization (WHO). Lassa fever fact sheet. World Health Organization; 2017. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/lassa-fever. Retrieved 31st October, 2020."},{"key":"5837_CR10","first-page":"177","volume-title":"Emergence and control of rodent-borne viral diseases","author":"JB McCormick","year":"1999","unstructured":"McCormick JB. Lassa fever. In: Saluzzo JF, Dodet B, editors. Emergence and control of rodent-borne viral diseases. Paris: Elsevier; 1999. p. 177\u201395."},{"key":"5837_CR11","doi-asserted-by":"publisher","unstructured":"Ter Meulen J, Lukashevich I, Sidibe K. Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. Am J Trop Med Hyg 1996; 55: 661\u2013666. https:\/\/doi.org\/https:\/\/doi.org\/10.4269\/ajtmh.1996.55.661.","DOI":"10.4269\/ajtmh.1996.55.661"},{"key":"5837_CR12","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/B978-1-4557-4801-3.00169-7","volume-title":"Mandell, Douglas and Bennett\u2019s principles and practice of infectious diseases","author":"A Seregin","year":"2015","unstructured":"Seregin A, Yun N, Paessler S. Lymphocytic choriomeningitis, Lassa fever, and the south American hemorrhagic fevers. In: Bennett JE, Dolin R, Blaser M, editors. Mandell, Douglas and Bennett\u2019s principles and practice of infectious diseases. 8th ed. Philadelphia: Elsevier Saunders; 2015. p. 2031\u20137.","edition":"8"},{"key":"5837_CR13","doi-asserted-by":"publisher","unstructured":"Raabe VN, Kann G, Ribner BS, Morales A, Varkey JB, Mehta AK, Lyon GM, Vanairsdale S, Faber K, Becker S, Eickmann M, Strecker T, Brown S, Patel K, De Leuw P, Schuettfort G, Stephan C, Rabenau H, Klena JD, Rollin PE, McElroy A, Str\u00f6her U, Nichol S, Kraft CS, Wolf T. Emory serious communicable diseases unit. Favipiravir and ribavirin treatment of epidemiologically linked cases of Lassa fever. Clin Infect Dis 2017; 65(5):855\u2013859. https:\/\/doi.org\/https:\/\/doi.org\/10.1093\/cid\/cix406.","DOI":"10.1093\/cid\/cix406"},{"issue":"6","key":"5837_CR14","doi-asserted-by":"crossref","first-page":"19117","DOI":"10.2807\/ese.14.06.19117-en","volume":"14","author":"A Kitching","year":"2009","unstructured":"Kitching A, Addiman S, Cathcart S, Bishop L, Krah\u00e9 D, Nicholas M, et al. A fatal case of Lassa fever in London, January 2009. Euro Surveill. 2009;14(6):19117.","journal-title":"Euro Surveill"},{"key":"5837_CR15","doi-asserted-by":"publisher","unstructured":"Haas WH, Breuer T, Pfaff G, Schmitz H, K\u00f6hler P, Asper M, et al. Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis 2003;36(10):1254\u20131258. https:\/\/doi.org\/https:\/\/doi.org\/10.1086\/374853.","DOI":"10.1086\/374853"},{"key":"5837_CR16","doi-asserted-by":"publisher","unstructured":"Bausch DG, Hadi CM, Khan SH, Lertora JJL. Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever. Clin Infect Dis 2010;51(12):1435\u20131441. https:\/\/doi.org\/https:\/\/doi.org\/10.1086\/657315.","DOI":"10.1086\/657315"},{"key":"5837_CR17","doi-asserted-by":"publisher","unstructured":"Ehichioya DU, Asogun DA, Ehimuan J, Okokhere PO, Pahlmann M, Olschlager S, et al. Hospital-based surveillance for Lassa fever in Edo state, Nigeria, 2005\u20132008. Tropical Med Int Health 2012;17(8):1001\u20131004. https:\/\/doi.org\/https:\/\/doi.org\/10.1111\/j.1365-3156.2012.03010.x.","DOI":"10.1111\/j.1365-3156.2012.03010.x"},{"key":"5837_CR18","doi-asserted-by":"publisher","unstructured":"Asogun DA, Adomeh DI, Ehimuan J, Odia I, Hass M, Gabriel M, Olschlager S, Becker-Ziaja B, Folarin O, Phelan E, et al. Molecular diagnostics for Lassa fever at Irrua specialist teaching hospital, Nigeria: Lessons learnt from two years of laboratory operation PLoS Negl Trop Dis 2012;6:e1839. https:\/\/doi.org\/https:\/\/doi.org\/10.1371\/journal.pntd.0001839.","DOI":"10.1371\/journal.pntd.0001839"},{"key":"5837_CR19","doi-asserted-by":"publisher","unstructured":"McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, Elliott LH, Belmont-Williams R. Lassa fever. Effective therapy with ribavirin. N Engl J Med 1986;314:20\u201326. https:\/\/doi.org\/https:\/\/doi.org\/10.1056\/nejm198601023140104.","DOI":"10.1056\/nejm198601023140104"},{"key":"5837_CR20","unstructured":"Britannica. Nigeria. Britannica; 2020. https:\/\/www.britannica.com\/place\/Nigeria. Retrieved 31st October, 2020."},{"key":"5837_CR21","unstructured":"World Population Review (WPR). Nigeria population review (Live). World Population Review; 2020. https:\/\/worldpopulationreview.com\/countries\/nigeria-population. Retrieved 31st October, 2020."},{"key":"5837_CR22","doi-asserted-by":"publisher","unstructured":"Okoro OA, Bamigboye E, Dan-Nwafor C, Umeokonkwo C, Ilori E, Yashe R, Balogun M, Nguku P, Ihekweazu C. Descriptive epidemiology of Lassa fever in Nigeria, 2012\u20132017. Pan Afri Med J 2020;37(15):1\u20137. https:\/\/doi.org\/https:\/\/doi.org\/10.11604\/pamj.2020.37.15.21160","DOI":"10.11604\/pamj.2020.37.15.21160"},{"key":"5837_CR23","unstructured":"Nigeria Center for Disease Control (NCDC). An update of Lassa fever outbreak in Nigeria. Nigeria Centre for Disease Control; 2020. https:\/\/ncdc.gov.ng\/diseases\/sitreps\/?cat=5&name=An%20update%20of%20Lassa%20fever%20outbreak%20in%20Nigeria. 4th October, 2020."},{"key":"5837_CR24","doi-asserted-by":"publisher","unstructured":"Zhao S, Musa SS, Fu H, He D, Qin J. Large-scale Lassa fever outbreaks in Nigeria: quantifying the association between disease reproduction number and local rainfall. Epidemiol Infect. 2020;148e4:1\u201312. https:\/\/doi.org\/https:\/\/doi.org\/10.1017\/S0950268819002267.","DOI":"10.1017\/S0950268819002267"},{"key":"5837_CR25","doi-asserted-by":"publisher","unstructured":"Fichet-Calvet E, Lecompte E, Koivogui L, Soropogui B, Dore A, Kourouma F, Sylla O, Daffis S, Koulemou K, ter Meulen J. Fluctuation of abundance and Lassa virus prevalence in Mastomys natalensis in Guinea, West Africa. Vector Borne Zoonotic Dis 2007;7:119\u2013128. https:\/\/doi.org\/https:\/\/doi.org\/10.1089\/vbz.2006.0520.","DOI":"10.1089\/vbz.2006.0520"},{"key":"5837_CR26","doi-asserted-by":"publisher","unstructured":"Mari-Saez A, Cherif HM, Camara A, Kourouma F, Sage M, Magassouba N, Fichet-Calvet E. Rodent control to fight Lassa fever: evaluation and lessons learned from a 4-year study in upper Guinea. PLoS Negl Trop Dis 2018.12:e0006829. https:\/\/doi.org\/https:\/\/doi.org\/10.1371\/journal.pntd.0006829.","DOI":"10.1371\/journal.pntd.0006829"},{"key":"5837_CR27","first-page":"286","volume":"130","author":"OO Adetola","year":"2019","unstructured":"Adetola OO, Adebisi MA. Impacts of deforestation on the spread of Mastomys natalensis in Nigeria. World Sci News. 2019;130:286\u201396.","journal-title":"World Sci News"},{"key":"5837_CR28","doi-asserted-by":"publisher","unstructured":"Chapagain T, Raizada MN. Agronomic challenges and opportunities for smallholder terrace agriculture in developing countries. Front Plant Sci 2017; 8: 331. https:\/\/doi.org\/https:\/\/doi.org\/10.3389\/fpls.2017.00331.","DOI":"10.3389\/fpls.2017.00331"},{"key":"5837_CR29","doi-asserted-by":"publisher","unstructured":"Abdullahi IN, Anka AU, Ghamba PE, Onukegbe NB, Amadu DO, Salami, MO. Need for preventive and control measures for Lassa fever through the one health strategic approach. Proceedings of Singapore Healthcare 2020;29(3):190\u2013194. https:\/\/doi.org\/https:\/\/doi.org\/10.1177\/2010105820932616.","DOI":"10.1177\/2010105820932616"},{"key":"5837_CR30","unstructured":"Adesina AS, Oyeyiola A, Gunther S, Fichet-Calvet E, Olayemi A. Phylogenetic analysis and prevalence of Lassa virus in multimammate mice within the highly endemic Edo-Ondo hotspot for Lassa fever, Nigeria. Proceedings of the 6th International Conference of Rodent Biology and Management & 16th Rodens et Spatium. 2018;p.121. https:\/\/ojs.openagrar.de\/index.php\/JKA\/issue\/view\/1703\/Julius%20K%C3%BChn-Archiv%20459. Retrieved 31st October, 2020."},{"key":"5837_CR31","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s13071-018-2991-5","volume":"11","author":"A Olayemi","year":"2018","unstructured":"Olayemi A, Oyeyiola A, Obadare A, Igbokwe J, Adesina AS, Onwe F, Ukwaja KN, Ajayi NA, Rieger T, Gunther S, et al. Widespread arenavirus occurrence and seroprevalence in small mammals. Nigeria Parasit Vectors. 2018;11:416 https:\/\/dx.doi.org\/10.1186%2Fs13071-018-2991-5.","journal-title":"Nigeria Parasit Vectors"},{"key":"5837_CR32","doi-asserted-by":"publisher","unstructured":"Igbokwe J, Awodiran MO, Oladejo OS, Olayemi A, Awopetu JI. Chromosomal analysis of small mammals from southwestern Nigeria. Mamm Res 2016;61:153\u2013159. https:\/\/doi.org\/https:\/\/doi.org\/10.1007\/s13364-015-0254-9.","DOI":"10.1007\/s13364-015-0254-9"},{"issue":"2","key":"5837_CR33","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/14772000.2017.1358220","volume":"16","author":"A Olayemi","year":"2017","unstructured":"Olayemi A, Obadare A, Oyeyiola A, Fasogbon S, Igbokwe J, Igbahenah F, Ortsega D, Gunther S, Verheven E, Fichet-Calvet E. Small mammal diversity and dynamics within Nigeria, with emphasis on reservoirs of the Lassa virus. Syst Biodivers. 2017;16(2):118\u201327 https:\/\/doi.org\/10.1080\/14772000.2017.1358220.","journal-title":"Syst Biodivers"},{"key":"5837_CR34","unstructured":"Nigeria Center for Disease Control (NCDC). Press Release: NCDC Reviews Lassa Fever outbreak response amidst reducing number of cases. Nigeria Center for Disease Control; 2019. https:\/\/ncdc.gov.ng\/news\/164\/pressrelease%3A-ncdc-reviews-lassa-fever-outbreak-response-amidst-reducingnumber-of-cases. Retrieved 31st October, 2020."},{"key":"5837_CR35","doi-asserted-by":"publisher","unstructured":"Usuwa IS, Akpa CO, Umeokonkwo CD, Umoke M, Oguanuo CS, Olorukooba AA, Bamigboye E, Balogun MS. Knowledge and risk perception towards Lassa fever infection among residents of affected communities in Ebonyi state, Nigeria: implications for risk communication. BMC Public Health 2020;20:217. https:\/\/doi.org\/https:\/\/doi.org\/10.1186\/s12889-020-8299-3.","DOI":"10.1186\/s12889-020-8299-3"},{"issue":"37","key":"5837_CR36","first-page":"166","volume":"5","author":"AK Adefisan","year":"2014","unstructured":"Adefisan AK. The level of awareness that rat is a vector of Lassa fever among the rural people in Ijebu north local government, Ogun state, Nigeria. J Educ Pract. 2014;5(37):166\u201370.","journal-title":"J Educ Pract"},{"key":"5837_CR37","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1098\/rstb.2001.0888","volume":"356","author":"LH Taylor","year":"2001","unstructured":"Taylor LH, Latham SM, Woolhouse MEJ. Risk factors for human disease emergence. Philos Trans R Soc B: Biol Sci. 2001;356:983\u20139 https:\/\/dx.doi.org\/10.1098%2Frstb.2001.0888.","journal-title":"Philos Trans R Soc B: Biol Sci"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-05837-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-021-05837-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-05837-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T05:51:55Z","timestamp":1619243515000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-05837-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5837"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-05837-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,5]]},"assertion":[{"value":"4 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}